A pharmacist checks the inventory. (Photo: Tyler Olson)
OPINION: Economist Noreena Hertz once said “We typically focus on anything that agrees with the outcome we want.” And certainly SB 790’s desired outcome – limiting any overprescription of more expensive drugs – seems to be what we – including myself – “want.” Unfortunately, the strict limits on “gifts” to providers from pharmaceutical manufacturers that it would impose seem a “solution in search of a problem.”
A senior medical practitioner on the phone with hospital records. (Photo: sirtravelalot, via Shutterstock)
OPINION: The California Assembly is currently considering a bill, Senate Bill 790, which would put in place severe restrictions around gifts or other financial benefits that pharmaceutical companies can give to medical professionals as part of marketing activities. Not only will the bill limit physician access to important information about new treatments, but it also insults the integrity of every physician practicing in California and is a threat to the patient-physician relationship.